STONNINGTON GROUP, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 281 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 6.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
STONNINGTON GROUP, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$507,082
-3.2%
12,019
-14.3%
0.13%
-8.3%
Q4 2022$523,890
-66.5%
14,019
-52.5%
0.14%
-67.4%
Q3 2022$1,566,000
+17.0%
29,519
+27.8%
0.44%
+24.2%
Q2 2022$1,339,000
-60.8%
23,097
-50.4%
0.36%
-56.4%
Q1 2022$3,413,000
-84.9%
46,597
-87.2%
0.82%
+24.9%
Q4 2021$22,609,000
+2097.2%
364,376
+1599.0%
0.65%
+184.3%
Q3 2021$1,029,000
-28.5%
21,447
-16.0%
0.23%
-28.1%
Q2 2021$1,439,000
-7.3%
25,547
+2.0%
0.32%
-14.9%
Q1 2021$1,552,00025,0470.38%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders